The COPD assessment test (CAT) is a commonly used disease-specific Patient-completed questionnaire assessing globally the impact of COPD (cough, sputum, dysnea, chest tighteness) on health status for evaluating functional impairment in patients with COPD. Is it applicable to COVID-19 patient or we should develop a new Patient Oriented Outcome Measure for the assessment of lung function for Pulmonary Rehabilitation of the COVID patients.
It is not known that how the CAT score performs in context of clinical pulmonary rehabilitation programmes or what the minimum clinically important difference is.
Symptoms of Covid-19 can be examined using the COPD assessment test (CAT) score, and dyspnea grade are examined using a ... Barriers in access to pulmonary rehabilitation. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266601/
Kindly check https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-COVID-19.pdf
Also check https://www.physio-pedia.com/Respiratory_Management_of_COVID_19
Chinaza Godswill Awuchi Thank you very much for your abutment and contribution.
Abdulridha Taha Sarhan Thank you sir for your active participation in the discussion.